Author: Shuya Lu; Qi Zhou; Liping Huang; Qianling Shi; Siya Zhao; Zijun Wang; Weiguo Li; Yuyi Tang; Yanfang Ma; Xufei Luo; Toshio Fukuoka; Hyeong Sik Ahn; Myeong Soo Lee; Zhengxiu Luo; Enmei Liu; Yaolong Chen; Chenyan Zhou; Donghong Peng
Title: Effectiveness and Safety of Glucocorticoids to Treat COVID-19: A Rapid Review and Meta-Analysis Document date: 2020_4_22
ID: 935r7w01_39
Snippet: CI: -7.6 to 9.5, I²=94.6%) patients. Subgroup analyses showed that using glucocorticoids did not shorten the absorption time of lung inflammation in patients with severe SARS regardless of severity (WMD=0.4 d, 95%CI: -4.2 to 5.1, I²=0%), or with mild SARS (WMD=1.3 d, 95%CI:-8.7 to 11.3, I²=95.5%) (Figure 7, Figure 8 )......
Document: CI: -7.6 to 9.5, I²=94.6%) patients. Subgroup analyses showed that using glucocorticoids did not shorten the absorption time of lung inflammation in patients with severe SARS regardless of severity (WMD=0.4 d, 95%CI: -4.2 to 5.1, I²=0%), or with mild SARS (WMD=1.3 d, 95%CI:-8.7 to 11.3, I²=95.5%) (Figure 7, Figure 8 ).
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date